MIRA INFORM REPORT

 

 

Report Date :

16.05.2014

 

IDENTIFICATION DETAILS

 

Name :

NEOSPAN PHARMA CARE PRIVATE LIMITED

 

 

Registered Office :

Old No.2, New No.5, Sowrashtra Nagar III Street, Choolaimedu, Chennai – 600094, Tamilnadu

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

21.04.2008

 

 

Com. Reg. No.:

18-067423

 

 

Capital Investment / Paid-up Capital :

Rs.0.100 Million

 

 

CIN No.:

[Company Identification No.]

U51397TN2008PTC067423

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CHEN07032E

 

 

PAN No.:

[Permanent Account No.]

AACCN7904P

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader of Pharma Products.

 

 

No. of Employees :

3 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (28)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 130

 

 

Status :

Small Company

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a small company in its field. Its scale of activities are limited.

 

There are accumulated losses recorded by the company.

 

However, trade relations are reported to be fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for small to medium business dealings with some caution.

 

Note: As confirmed by Mr. Antony Charles Siluvai Francies, Director that the company was established in the year 2003 as partnership concern with name Span Pharma and later got converted into private limited company.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

US investment bank Goldman Sachs has upgraded its outlook on Indian markets as it expects positive impact of the election cycle.

 

India’s economy may grow 4.7 % in the current financial year, lower than the official estimate of 4.9 %, Fitch Rating said. The global rating agency expects the economy to pick up in the next two financial years.

 

Global ratings agency Standard & Poor said increasing focus by India Inc on lowering debt is likely to improve their credit profiles.

 

Singapore (1.1 million Indian tourists in 2012), Thailand (one million), the United Arab Emirates ().98 million) and Malaysia ().82 million) emerged as the preferred holidays hotspots for Indians. The total figure is expected to increase to 1.93 million by 2017, according to the latest Eurmonitor international report.

 

There is a $29.34 bn outward foreign direct investment by domestic companies between April and January of 2013/14 which has seen some signs of recovery according to a Care Ratings report.

 

There are 264 number of new companies being set up every day on average during 2014. Most of them are registered in Mumbai. India had 1.38 million registered companies at the end of January, 2014.

 

Twitter like messaging service Weibo Corporation has filed to raise $ 500 million via a US initial public offering. Alibaba, which owns a stake in Weibo is expected to raise about $ 15 billion New York this year in the highest profile Internet IPO since Facebook’s in 2012.

 

Bharti Airtel has raised Rs.2453.2 crore (350 million Swiss Francs) by selling six-year bonds at a coupon rate of three per cent and maturing in 2020. This is the largest ever bond offering by an Indian company in Swiss Francs. Bharat Petroleum Corporation raised 175 million Swiss Francs by selling five year bonds at 2.98 % coupon rate in February.

 

Indian Oil Corporation plans to invest Rs 7650 crore in setting up a petrochemical complex at its almost complete Paradip refinery in Odhisha in three to four years. The company board is set to consider the setting up of a 700000 tonne per annum polypropylene plant at an estimated cost at Rs.3150 crore.

 

Global chief information officers at gathering in Bangalore in April to meet Indian startups at an event called Tech50 Watchout for Little Eye Labs-Facebook type deals in the making.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Antony Charles Siluvai Francies

Designation :

Director

Contact No.:

91-9841213391

Date :

15.05.2014

 

 

LOCATIONS

 

Registered Office :

Old No.2, New No.5, Sowrashtra Nagar III Street, Choolaimedu, Chennai – 600094, Tamilnadu, India

Tel. No.:

91-44-42657117

Mobile No.:

91-9841213391 (Mr. Antony Charles Siluvai Francies)

Fax No.:

Not Available

E-Mail :

sfacharlesfernando@hotmail.com

neospanpharma@gmail.com

tnfernando@hotmail.com

sfacharlesdernando@hotmail.com

Area :

240 Sq. Ft.

Location :

Rented

 

 

DIRECTORS

 

As on 28.09.2013

 

Name :

Mr. Antony Charles Siluvai Francies

Designation :

Director

Address :

No. 363/2, Baba Nagar, 15th Street, Villivakkam, Chennai – 600049, Tamilnadu, India

Date of Birth/Age :

12.03.1966

Date of Appointment :

21.04.2008

DIN No.:

02066193

 

 

Name :

Neola Jancy

Designation :

Director

Address :

No. 363/2, Baba Nagar, 15th Street, Villivakkam, Chennai – 600049, Tamilnadu, India

Date of Birth/Age :

14.03.1968

Date of Appointment :

21.04.2008

DIN No.:

02093644

 

 

MAJOR SHAREHOLDERS

 

As on 28.09.2013

 

Names of Shareholders

No. of Shares

% of Holding

Antony Charles Siluvai Francies

2500

25.00

T. Newman Fernando

2500

25.00

C. Latha Newman

2500

25.00

Neola Jancy

2500

25.00

Total

10000

100.00

 

 

 


Equity Share Break up (Percentage of Total Equity)

 

As on 28.09.2013

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Trader of Pharma Products.

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Suppliers :

Abbott Healthcare Limited

 

 

Customers :

Mehta Hospital

 

 

No. of Employees :

3 (Approximately)

 

 

Bankers :

Indian Overseas Bank, Choolaimedu, Chennai , Tamilnadu, India

 

 

Facilities :

Cash Credit = Rs.0.350 Million (From Indian Overseas Bank)

 

SECURED LOANS

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Long Term Borrowings

 

 

HDFC Auto Loan I

[Security - Motor Car]

[Repayment Term is 50 installments of which 3 installments are due as on 31-03-2013]

0.025

0.126

HDFC Auto Loan II

[Security - Motor Car]

[Repayment Term is 50 installments of which 3 installments are due as on 31-03-2013]

0.025

0.126

Total

0.050

0.252

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Chandramouli

Chartered Accountants

Address :

New No. 24/1, Vijayalakshmi Steet, Mahalingapuram, Chennai – 600004, Tamilnadu, India

PAN No.:

AAFPC0818B

 

 

 

CAPITAL STRUCTURE

 

As on 28.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

Rs.10/- each

Rs.0.100 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

Rs.10/- each

Rs.0.100 Million

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

0.100

0.100

0.100

(b) Reserves & Surplus

(0.067)

(0.093)

(0.109)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

0.033

0.007

(0.009)

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

1.396

1.598

1.799

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

ther long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

1.396

1.598

1.799

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

1.010

0.583

0.709

(c) Other current liabilities

0.163

0.277

0.176

(d) Short-term provisions

0.020

0.022

0.010

Total Current Liabilities (4)

1.193

0.882

0.895

 

 

 

 

TOTAL

2.622

2.487

2.685

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

0.315

0.399

0.528

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.066

0.058

0.048

(d)  Long-term Loan and Advances

0.016

0.016

0.016

(e) Other Non-current assets

0.000

0.012

0.000

Total Non-Current Assets

0.397

0.485

0.592

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

0.999

1.239

1.163

(c) Trade receivables

0.670

0.516

0.728

(d) Cash and cash equivalents

0.518

0.193

0.117

(e) Short-term loans and advances

0.038

0.054

0.061

(f) Other current assets

0.000

0.000

0.024

Total Current Assets

2.225

2.002

2.093

 

 

 

 

TOTAL

2.622

2.487

2.685

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

 

 

GROSS INCOME

15.786

14.605

13.398

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

0.148

0.162

0.144

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                    

0.110

0.134

0.178

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX

0.038

0.028

(0.034)

 

 

 

 

 

Less

TAX                                                     

0.012

0.012

(0.007)

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX

0.026

0.016

(0.027)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(0.093)

(0.109)

(0.082)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(0.067)

(0.093)

(0.109)

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

2.60

1.60

(2.70)

 

 

Particulars

 

 

 

31.03.2014

Sales Turnover (Approximately)

 

 

13.000

 

Expected Sales (2014-2015): Rs.30.000 Millions

 

The above information has been parted by Mr. Antony Charles Siluvai Francies

 

 


KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Debt Equity Ratio

(Total Debt /Networth)

 

42.30

228.29

(199.89)

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.87

2.27

2.34

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Share Capital

0.100

0.100

0.100

Reserves & Surplus

(0.109)

(0.093)

(0.067)

Net worth

(0.009)

0.007

0.033

 

 

 

 

long-term borrowings

1.799

1.598

1.396

Short term borrowings

0.000

0.000

0.000

Total borrowings

1.799

1.598

1.396

Debt/Equity ratio

(199.889)

228.286

42.303

 

 

 


YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Gross Income

13.398

14.605

15.786

 

 

9.009

8.086

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Gross Income

13.398

14.605

15.786

Profit

(0.027)

0.016

0.026

 

(0.20%)

0.11%

0.16%

 


LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

UNSECURED LOANS:

 

Particulars

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Long Term Borrowings

 

 

Loans and Advances from Related Parties

 

 

Directors & Shareholders

[Repayable after 36 months]

1.346

1.346

Total

1.346

1.346

 

OPERATIONAL RESULT

 

The Directors bring to the attention of the shareholders about the tough competition in the health sector environment. In spite of the competition envisaged they feel that the Health sector is poised for a better growth in future and correspondingly expects a better performance by the company in the future years.

 

NO CHARGES EXIST FOR THE COMPANY

 

FIXED ASSETS:

 

·         Land

·         Two Wheelers

·         Refrigerator

·         Generator

·         Air Conditioner

·         Vaccum Cleaner

·         Motor cars

·         Building

·         Computer

·         Vehicles

 

 

 

 

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.59.47

UK Pound

1

Rs.99.70

Euro

1

Rs.81.55

 

 

INFORMATION DETAILS

 

Information Gathered by :

HTL

 

 

Analysis Done by :

SUM

 

 

Report Prepared by :

VNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

28

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.